China's AI-driven biotech advances precision medicine infrastructure and global health equity
Original framing: “China AI boosts cancer screening, rare disease diagnosis” — South China Morning Post
In contrast to China's data-centric approach, many Indigenous health systems prioritize relational knowledge and community-based diagnostics. These models offer alternative pathways to health equity that challenge the individualistic framing of AI-driven precision medicine.
China's AI-driven biotech advancements represent a convergence of historical state-led knowledge systems, modern data infrastructures, and global health inequities.
While these technologies offer transformative potential, their impact is mediated by power dynamics in data ownership, cultural epistemologies, and access to healthcare. Integrating Indigenous and community-based health models with AI diagnostics can create more equitable and holistic health systems. Historical precedents from TCM and global health governance suggest that systemic change requires reimagining who controls health knowledge and for whose benefit. Future pathways must prioritize participatory governance and cross-cultural collaboration to avoid replicating colonial patterns of knowledge extraction and exclusion.